News

A 56-year-old man attended a sexual health clinic for asymptomatic rectal Chlamydia trachomatis treatment. Patient history ...
The Food and Drug Administration has approved lenacapavir, a breakthrough medication that reduces the risk of contracting HIV ...
Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the ...
Two drugs to treat Alzheimer’s disease have been rejected for use on the NHS because their benefits are “too small” to ...
Brain scientists have made a breakthrough that could help diagnose Parkinson's disease and Multiple System Atrophy much ...
Researchers at Indiana University are developing a small device called Isaac that uses a person's breath to test blood sugar ...
Yeztugo, generic name lenacapavir (LEN), has been approved after nearly eliminating the spread of HIV among trial patients.
In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.
Michael Shanks is upset that his feature debut, the Dave Franco and Alison Brie Sundance hit 'Together,' is being accused of ...
USC baseball certainly appears to be on the upswing right now. The Trojans are coming off of a season in which they made the NCAS Tournament for the first time in a decade. With head coach Andy ...
Last year, Lola Young released her second studio album, This Wasn’t Meant for You Anyway, which housed her breakthrough ...
Karen Knudsen is leading Sean Parker’s cancer immunotherapy incubator where philanthropy and venture capital meet.